<?xml version="1.0" encoding="UTF-8"?>
<ref id="B335-molecules-24-01364" class="ref">
 <label class="label">335.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Bezerra</surname>
    <given-names class="given-names">D.P.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Pessoa</surname>
    <given-names class="given-names">C.</given-names>
   </name>
   <name class="name">
    <surname class="surname">de Moraes</surname>
    <given-names class="given-names">M.O.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Saker-Neto</surname>
    <given-names class="given-names">N.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Silveira</surname>
    <given-names class="given-names">E.R.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Costa-Lotufo</surname>
    <given-names class="given-names">L.V.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Overview of the therapeutic potential of piplartine (piperlongumine)</article-title>
  <source class="source">Eur. J. Pharm. Sci.</source>
  <year class="year">2013</year>
  <volume class="volume">48</volume>
  <fpage class="fpage">453</fpage>
  <lpage class="lpage">463</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1016/j.ejps.2012.12.003</pub-id>
  <?supplied-pmid 23238172?>
  <pub-id pub-id-type="pmid" class="pub-id">23238172</pub-id>
 </element-citation>
</ref>
